Zimmer Holdings Inc. (ZMH)

Zimmer Holdings, Inc. and its subsidiaries design, develop, manufacture, and market reconstructive orthopaedic implants in the Americas, Europe, and Asia Pacific. It offers joint and dental implants, spinal implants, trauma products, and related orthopaedic surgical products. Its joint reconstructive implants restore function lost due to disease or trauma in joints, such as knees, hips, shoulders, and elbows. The company’s dental reconstructive implants restore function and aesthetics in patients that have lost teeth due to trauma or disease. Its spinal implants are used by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various regions of the spine. Zimmer Holdings’ trauma products are used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. Its related orthopaedic surgical products include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. The company’s customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, distributors, and healthcare dealers. Zimmer Holdings markets and sells its products directly, as well as through stocking distributors and healthcare dealers. The company was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Holdings Inc. (NYSE:ZMH) operates independently of Bristol-Myers Squibb Co. as of August 6, 2001.

For the nine months ended 30 September 2006, Zimmer Holdings, Inc.'s revenues increased 5% to $2.56B. Net income increased 11% to $589.8M. Revenues reflect higher sales from Americas division, an increase in revenues from Europe segment and higher income from Asia Pacific markets. Net income also reflects higher gross margins, decreased acquisition, integration & other cost and the presence of interest income.